Search research articles
Contact Us
Filters
Showing results (691-700 of 1,217) with videos related to
Page
of 122
Sort By:
Journal of the American Society of Nephrology : JASN
|
February 22, 2002
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion
Daniel Zehnder, Rosemary Bland, Ravinder S Chana, et al.
British Journal of Haematology
|
May 1, 1994
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation
L J Ayash, A Elias, M Hunt, et al.
Canadian Journal of Kidney Health and Disease
|
November 11, 2017
Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' Perceptions
Sharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, et al.
The Lancet. Diabetes & Endocrinology
|
April 18, 2019
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
Carol Pollock, Bergur Stefánsson, Daniel Reyner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study
L J Ayash, A Elias, C Wheeler, et al.
NEJM Evidence
|
August 26, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease
Jeffrey T Ha, Swapnil Hiremath, Min Jun, et al.
Cell Reports
|
May 4, 2022
Evidence for reduced BRCA2 functional activity in Homo sapiens after divergence from the chimpanzee-human last common ancestor
Jinlong Huang, Yi Zhong, Alvin P Makohon-Moore, et al.
Plos Genetics
|
September 19, 2009
Tnni3k modifies disease progression in murine models of cardiomyopathy
Ferrin C Wheeler, Hao Tang, Odessa A Marks, et al.
Kidney International
|
July 4, 2008
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Francesco Locatelli, Allen R Nissenson, Brendan J Barrett, et al.
Human Molecular Genetics
|
February 18, 2003
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
Silvia Gines, Ihn Sik Seong, Elisa Fossale, et al.
Page
of 122
Search research articles
Search
Showing results (691-700 of 1,217) with videos related to
Sort By:
Page
of 122
Journal of the American Society of Nephrology : JASN
|
February 22, 2002
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion
Daniel Zehnder, Rosemary Bland, Ravinder S Chana, et al.
British Journal of Haematology
|
May 1, 1994
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation
L J Ayash, A Elias, M Hunt, et al.
Canadian Journal of Kidney Health and Disease
|
November 11, 2017
Sex Hormone Status in Women With Chronic Kidney Disease: Survey of Nephrologists' and Renal Allied Health Care Providers' Perceptions
Sharanya Ramesh, Matthew T James, Jayna M Holroyd-Leduc, et al.
The Lancet. Diabetes & Endocrinology
|
April 18, 2019
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
Carol Pollock, Bergur Stefánsson, Daniel Reyner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study
L J Ayash, A Elias, C Wheeler, et al.
NEJM Evidence
|
August 26, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease
Jeffrey T Ha, Swapnil Hiremath, Min Jun, et al.
Cell Reports
|
May 4, 2022
Evidence for reduced BRCA2 functional activity in Homo sapiens after divergence from the chimpanzee-human last common ancestor
Jinlong Huang, Yi Zhong, Alvin P Makohon-Moore, et al.
Plos Genetics
|
September 19, 2009
Tnni3k modifies disease progression in murine models of cardiomyopathy
Ferrin C Wheeler, Hao Tang, Odessa A Marks, et al.
Kidney International
|
July 4, 2008
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Francesco Locatelli, Allen R Nissenson, Brendan J Barrett, et al.
Human Molecular Genetics
|
February 18, 2003
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
Silvia Gines, Ihn Sik Seong, Elisa Fossale, et al.
Page
of 122